loadpatents
Patent applications and USPTO patent grants for Treu; Matthias.The latest application filed is for "tosylacetate based compounds and derivatives thereof as phgdh inhibitors".
Patent | Date |
---|---|
Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors Grant 11,304,929 - Weinstabl , et al. April 19, 2 | 2022-04-19 |
Tosylacetate Based Compounds And Derivatives Thereof As Phgdh Inhibitors App 20220008386 - WEINSTABL; Harald ;   et al. | 2022-01-13 |
Annulated 2-amino-3-cyano Thiophenes And Derivatives For The Treatment Of Cancer App 20210380574 - ABBOTT; Jason ;   et al. | 2021-12-09 |
[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS App 20210332054 - WILDING; Birgit ;   et al. | 2021-10-28 |
5,8-dimethyl-9-phenyl-5,8-dihydro-6H-pyrazolo[3,4-h]quinazolin-2-yl)-(1H-p- yrazol-3-yl)-amines as IGF-1R/IR inhibitors Grant 10,414,769 - Treu , et al. Sept | 2019-09-17 |
New 5,8-dimethyl-9-phenyl-5,8-dihydro-6h-pyrazolo[3,4-h]quinazolin-2-yl)-(- 1h-pyrazol-3-yl)-amines And Derivatives As Igf-1r/ir Inhibitors App 20180141948 - TREU; Matthias ;   et al. | 2018-05-24 |
5,8-dihydro-6H-pyrazolo[3,4-h]quinazolines as IGF-1R/IR inhibitors Grant 9,150,578 - Treu October 6, 2 | 2015-10-06 |
Compounds Grant 8,853,420 - Treu , et al. October 7, 2 | 2014-10-07 |
Aminopyrazoloquinazolines Grant 8,735,386 - Treu May 27, 2 | 2014-05-27 |
Compounds Grant 8,623,887 - Zahn , et al. January 7, 2 | 2014-01-07 |
2,4-diamino-pyrimidines As Aurora Inhibitors App 20130281429 - ZAHN; Stephan Karl ;   et al. | 2013-10-24 |
Benzylic oxindole pyrimidines Grant 8,546,443 - Treu , et al. October 1, 2 | 2013-10-01 |
New 5,8-dihydro-6h-pyrazolo[3,4-h]quinazolines As Igf-1r/ir Inhibitors App 20130190305 - TREU; Matthias | 2013-07-25 |
Benzylic Oxindole Pyrimidines App 20120329771 - TREU; Matthias ;   et al. | 2012-12-27 |
Indoline Derivatives And Their Use In Treating Disease-states Such As Cancer App 20120270859 - TREU; Matthias ;   et al. | 2012-10-25 |
Aminopyrazoloquinazolines App 20120238542 - Treu; Matthias | 2012-09-20 |
Substituted indolines as tyrosine kinase inhibitors Grant 8,207,179 - Engelhardt , et al. June 26, 2 | 2012-06-26 |
Compounds App 20110263565 - Treu; Matthias ;   et al. | 2011-10-27 |
2,4-diamino-pyrimidines As Aurora Inhibitors App 20110251174 - ZAHN; Stephan Karl ;   et al. | 2011-10-13 |
3-(aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors Grant 7,981,880 - Treu , et al. July 19, 2 | 2011-07-19 |
New Compounds App 20100222331 - Engelhardt; Harald ;   et al. | 2010-09-02 |
Indoline Derivatives And Their Use In Treating Disease-states Such As Cancer App 20100184747 - Treu; Matthias ;   et al. | 2010-07-22 |
Compounds App 20100144706 - Zahn; Stephan Karl ;   et al. | 2010-06-10 |
Pyrrolobenzimidazolones and their use as anti-proliferative agents Grant 7,714,010 - McConnel , et al. May 11, 2 | 2010-05-11 |
New compounds App 20090163467 - Zahn; Stephan Karl ;   et al. | 2009-06-25 |
3- (aminomethyliden) 2-indolinone Derivates And Their Use As Cell Proliferation Inhibitors App 20090105216 - Treu; Matthias ;   et al. | 2009-04-23 |
2,4-diamino-pyrimidines as aurora inhibitors App 20070032514 - Zahn; Stephan Karl ;   et al. | 2007-02-08 |
Derivatives and analogs of galanthamine App 20070027138 - Jordis; Ulrich ;   et al. | 2007-02-01 |
Derivatives and analogs of galanthamine Grant 7,166,588 - Jordis , et al. January 23, 2 | 2007-01-23 |
Alpha-Carbolines as CDK-1 inhibitors App 20070004684 - Sennhenn; Peter ;   et al. | 2007-01-04 |
Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereof App 20060069251 - Jordis; Ulrich ;   et al. | 2006-03-30 |
Pyrrolobenzimidazolones and their use as anti-proliferative agents App 20050261350 - McConnel, Darryl ;   et al. | 2005-11-24 |
Novel derivatives and analogues of galanthamin App 20030199493 - Jordis, Ulrich ;   et al. | 2003-10-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.